Loading…

5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use

5-Fluorouracil (5-FU) is a well-known chemotherapy drug, used for over 70 years in the treatment of several types of cancer. Topically, 5-FU has shown potential effect to treat premalignant and malignant lesions. However, the efficiency of topical 5-FU administration is limited to treat superficial...

Full description

Saved in:
Bibliographic Details
Published in:Journal of drug delivery science and technology 2021-02, Vol.61, p.102155, Article 102155
Main Authors: Ewert de Oliveira, Beatriz, Junqueira Amorim, Otávio Henrique, Lima, Lonetá Lauro, Rezende, Rodrigo Alvarenga, Mestnik, Natalia Cammarosano, Bagatin, Ediléia, Leonardi, Gislaine Ricci
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c303t-9c918eabca6c20bc37ed45b38f0e6ff470292409509e990e81d9dfd669e5f5f53
cites cdi_FETCH-LOGICAL-c303t-9c918eabca6c20bc37ed45b38f0e6ff470292409509e990e81d9dfd669e5f5f53
container_end_page
container_issue
container_start_page 102155
container_title Journal of drug delivery science and technology
container_volume 61
creator Ewert de Oliveira, Beatriz
Junqueira Amorim, Otávio Henrique
Lima, Lonetá Lauro
Rezende, Rodrigo Alvarenga
Mestnik, Natalia Cammarosano
Bagatin, Ediléia
Leonardi, Gislaine Ricci
description 5-Fluorouracil (5-FU) is a well-known chemotherapy drug, used for over 70 years in the treatment of several types of cancer. Topically, 5-FU has shown potential effect to treat premalignant and malignant lesions. However, the efficiency of topical 5-FU administration is limited to treat superficial pre-carcinogenic lesions. In this review we present the main characteristics of 5-FU, including its mechanism of action, dissolution, and bioavailability. Moreover, we highlight the delivery systems under development that include 5-FU carriers in topical treatments. Microemulsions and nanocarriers have demonstrated significant impact on the bioavailability of 5-FU in vitro and in vivo, increasing the drug effects on deeper layers of the skin, which has shown promising results in the treatment of precancerous and cancerous lesions. According to authors of clinical pilot studies, 5-FU occlusive dressing, 5-FU chemowrap, 5-FU transdermal, and their combination, resulting in a triple therapy, are more effective compared with cream formulation to treat precancer widespread in a skin area. Conclusion: Thus, by this review, we demonstrate that the delivery system under consideration greatly impacts 5-FU effects on the skin. [Display omitted] •Nanocarriers and microemulsions have shown high affinity for skin, promoting targetable delivery of 5-FU for topical use.•Chemowrap and combination therapy are innovative approaches for improving the healing outcome in precancerous skin.•Smart chemowrap using biosensors and pH-sensitive biomaterial can increase the cure rate of widespread skin precancer.
doi_str_mv 10.1016/j.jddst.2020.102155
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_jddst_2020_102155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1773224720314441</els_id><sourcerecordid>S1773224720314441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-9c918eabca6c20bc37ed45b38f0e6ff470292409509e990e81d9dfd669e5f5f53</originalsourceid><addsrcrecordid>eNp9kM1OwzAMgHMAiWnsCbjkAehw0r_lwAFNDCZN4gInDlGaOJCqa6YkrdS3p2OckQ-2bH2W_RFyx2DNgFUP7bo1JqY1B37ucFaWV2TB6jrPOC_qG7KKsQUAVgMruFiQzzLbdYMPfghKu-6eur73o0puRGrC8EUNdnMdJhqnmPAYafIU-2_Va6SN82pUrlON61yaqPVhHp-cVh0dIt6Sa6u6iKu_vCQfu-f37Wt2eHvZb58Omc4hT5nQgm1QNVpVmkOj8xpNUTb5xgJW1hY1cMELECUIFAJww4ww1lSVwNLOkS9Jftmrg48xoJWn4I4qTJKBPGuRrfzVIs9a5EXLTD1eKJxPGx0GGbXD-S3jAuokjXf_8j_zUXAc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use</title><source>ScienceDirect Journals</source><creator>Ewert de Oliveira, Beatriz ; Junqueira Amorim, Otávio Henrique ; Lima, Lonetá Lauro ; Rezende, Rodrigo Alvarenga ; Mestnik, Natalia Cammarosano ; Bagatin, Ediléia ; Leonardi, Gislaine Ricci</creator><creatorcontrib>Ewert de Oliveira, Beatriz ; Junqueira Amorim, Otávio Henrique ; Lima, Lonetá Lauro ; Rezende, Rodrigo Alvarenga ; Mestnik, Natalia Cammarosano ; Bagatin, Ediléia ; Leonardi, Gislaine Ricci</creatorcontrib><description>5-Fluorouracil (5-FU) is a well-known chemotherapy drug, used for over 70 years in the treatment of several types of cancer. Topically, 5-FU has shown potential effect to treat premalignant and malignant lesions. However, the efficiency of topical 5-FU administration is limited to treat superficial pre-carcinogenic lesions. In this review we present the main characteristics of 5-FU, including its mechanism of action, dissolution, and bioavailability. Moreover, we highlight the delivery systems under development that include 5-FU carriers in topical treatments. Microemulsions and nanocarriers have demonstrated significant impact on the bioavailability of 5-FU in vitro and in vivo, increasing the drug effects on deeper layers of the skin, which has shown promising results in the treatment of precancerous and cancerous lesions. According to authors of clinical pilot studies, 5-FU occlusive dressing, 5-FU chemowrap, 5-FU transdermal, and their combination, resulting in a triple therapy, are more effective compared with cream formulation to treat precancer widespread in a skin area. Conclusion: Thus, by this review, we demonstrate that the delivery system under consideration greatly impacts 5-FU effects on the skin. [Display omitted] •Nanocarriers and microemulsions have shown high affinity for skin, promoting targetable delivery of 5-FU for topical use.•Chemowrap and combination therapy are innovative approaches for improving the healing outcome in precancerous skin.•Smart chemowrap using biosensors and pH-sensitive biomaterial can increase the cure rate of widespread skin precancer.</description><identifier>ISSN: 1773-2247</identifier><identifier>DOI: 10.1016/j.jddst.2020.102155</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>5-Fluorouracil ; Chemowrap ; Drug delivery ; Nanocarriers ; Skin ; Skin cancer ; Targeting</subject><ispartof>Journal of drug delivery science and technology, 2021-02, Vol.61, p.102155, Article 102155</ispartof><rights>2020 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-9c918eabca6c20bc37ed45b38f0e6ff470292409509e990e81d9dfd669e5f5f53</citedby><cites>FETCH-LOGICAL-c303t-9c918eabca6c20bc37ed45b38f0e6ff470292409509e990e81d9dfd669e5f5f53</cites><orcidid>0000-0002-7126-1326 ; 0000-0001-7190-8241 ; 0000-0002-6604-5880</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ewert de Oliveira, Beatriz</creatorcontrib><creatorcontrib>Junqueira Amorim, Otávio Henrique</creatorcontrib><creatorcontrib>Lima, Lonetá Lauro</creatorcontrib><creatorcontrib>Rezende, Rodrigo Alvarenga</creatorcontrib><creatorcontrib>Mestnik, Natalia Cammarosano</creatorcontrib><creatorcontrib>Bagatin, Ediléia</creatorcontrib><creatorcontrib>Leonardi, Gislaine Ricci</creatorcontrib><title>5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use</title><title>Journal of drug delivery science and technology</title><description>5-Fluorouracil (5-FU) is a well-known chemotherapy drug, used for over 70 years in the treatment of several types of cancer. Topically, 5-FU has shown potential effect to treat premalignant and malignant lesions. However, the efficiency of topical 5-FU administration is limited to treat superficial pre-carcinogenic lesions. In this review we present the main characteristics of 5-FU, including its mechanism of action, dissolution, and bioavailability. Moreover, we highlight the delivery systems under development that include 5-FU carriers in topical treatments. Microemulsions and nanocarriers have demonstrated significant impact on the bioavailability of 5-FU in vitro and in vivo, increasing the drug effects on deeper layers of the skin, which has shown promising results in the treatment of precancerous and cancerous lesions. According to authors of clinical pilot studies, 5-FU occlusive dressing, 5-FU chemowrap, 5-FU transdermal, and their combination, resulting in a triple therapy, are more effective compared with cream formulation to treat precancer widespread in a skin area. Conclusion: Thus, by this review, we demonstrate that the delivery system under consideration greatly impacts 5-FU effects on the skin. [Display omitted] •Nanocarriers and microemulsions have shown high affinity for skin, promoting targetable delivery of 5-FU for topical use.•Chemowrap and combination therapy are innovative approaches for improving the healing outcome in precancerous skin.•Smart chemowrap using biosensors and pH-sensitive biomaterial can increase the cure rate of widespread skin precancer.</description><subject>5-Fluorouracil</subject><subject>Chemowrap</subject><subject>Drug delivery</subject><subject>Nanocarriers</subject><subject>Skin</subject><subject>Skin cancer</subject><subject>Targeting</subject><issn>1773-2247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAMgHMAiWnsCbjkAehw0r_lwAFNDCZN4gInDlGaOJCqa6YkrdS3p2OckQ-2bH2W_RFyx2DNgFUP7bo1JqY1B37ucFaWV2TB6jrPOC_qG7KKsQUAVgMruFiQzzLbdYMPfghKu-6eur73o0puRGrC8EUNdnMdJhqnmPAYafIU-2_Va6SN82pUrlON61yaqPVhHp-cVh0dIt6Sa6u6iKu_vCQfu-f37Wt2eHvZb58Omc4hT5nQgm1QNVpVmkOj8xpNUTb5xgJW1hY1cMELECUIFAJww4ww1lSVwNLOkS9Jftmrg48xoJWn4I4qTJKBPGuRrfzVIs9a5EXLTD1eKJxPGx0GGbXD-S3jAuokjXf_8j_zUXAc</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Ewert de Oliveira, Beatriz</creator><creator>Junqueira Amorim, Otávio Henrique</creator><creator>Lima, Lonetá Lauro</creator><creator>Rezende, Rodrigo Alvarenga</creator><creator>Mestnik, Natalia Cammarosano</creator><creator>Bagatin, Ediléia</creator><creator>Leonardi, Gislaine Ricci</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7126-1326</orcidid><orcidid>https://orcid.org/0000-0001-7190-8241</orcidid><orcidid>https://orcid.org/0000-0002-6604-5880</orcidid></search><sort><creationdate>202102</creationdate><title>5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use</title><author>Ewert de Oliveira, Beatriz ; Junqueira Amorim, Otávio Henrique ; Lima, Lonetá Lauro ; Rezende, Rodrigo Alvarenga ; Mestnik, Natalia Cammarosano ; Bagatin, Ediléia ; Leonardi, Gislaine Ricci</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-9c918eabca6c20bc37ed45b38f0e6ff470292409509e990e81d9dfd669e5f5f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>5-Fluorouracil</topic><topic>Chemowrap</topic><topic>Drug delivery</topic><topic>Nanocarriers</topic><topic>Skin</topic><topic>Skin cancer</topic><topic>Targeting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ewert de Oliveira, Beatriz</creatorcontrib><creatorcontrib>Junqueira Amorim, Otávio Henrique</creatorcontrib><creatorcontrib>Lima, Lonetá Lauro</creatorcontrib><creatorcontrib>Rezende, Rodrigo Alvarenga</creatorcontrib><creatorcontrib>Mestnik, Natalia Cammarosano</creatorcontrib><creatorcontrib>Bagatin, Ediléia</creatorcontrib><creatorcontrib>Leonardi, Gislaine Ricci</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of drug delivery science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ewert de Oliveira, Beatriz</au><au>Junqueira Amorim, Otávio Henrique</au><au>Lima, Lonetá Lauro</au><au>Rezende, Rodrigo Alvarenga</au><au>Mestnik, Natalia Cammarosano</au><au>Bagatin, Ediléia</au><au>Leonardi, Gislaine Ricci</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use</atitle><jtitle>Journal of drug delivery science and technology</jtitle><date>2021-02</date><risdate>2021</risdate><volume>61</volume><spage>102155</spage><pages>102155-</pages><artnum>102155</artnum><issn>1773-2247</issn><abstract>5-Fluorouracil (5-FU) is a well-known chemotherapy drug, used for over 70 years in the treatment of several types of cancer. Topically, 5-FU has shown potential effect to treat premalignant and malignant lesions. However, the efficiency of topical 5-FU administration is limited to treat superficial pre-carcinogenic lesions. In this review we present the main characteristics of 5-FU, including its mechanism of action, dissolution, and bioavailability. Moreover, we highlight the delivery systems under development that include 5-FU carriers in topical treatments. Microemulsions and nanocarriers have demonstrated significant impact on the bioavailability of 5-FU in vitro and in vivo, increasing the drug effects on deeper layers of the skin, which has shown promising results in the treatment of precancerous and cancerous lesions. According to authors of clinical pilot studies, 5-FU occlusive dressing, 5-FU chemowrap, 5-FU transdermal, and their combination, resulting in a triple therapy, are more effective compared with cream formulation to treat precancer widespread in a skin area. Conclusion: Thus, by this review, we demonstrate that the delivery system under consideration greatly impacts 5-FU effects on the skin. [Display omitted] •Nanocarriers and microemulsions have shown high affinity for skin, promoting targetable delivery of 5-FU for topical use.•Chemowrap and combination therapy are innovative approaches for improving the healing outcome in precancerous skin.•Smart chemowrap using biosensors and pH-sensitive biomaterial can increase the cure rate of widespread skin precancer.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.jddst.2020.102155</doi><orcidid>https://orcid.org/0000-0002-7126-1326</orcidid><orcidid>https://orcid.org/0000-0001-7190-8241</orcidid><orcidid>https://orcid.org/0000-0002-6604-5880</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1773-2247
ispartof Journal of drug delivery science and technology, 2021-02, Vol.61, p.102155, Article 102155
issn 1773-2247
language eng
recordid cdi_crossref_primary_10_1016_j_jddst_2020_102155
source ScienceDirect Journals
subjects 5-Fluorouracil
Chemowrap
Drug delivery
Nanocarriers
Skin
Skin cancer
Targeting
title 5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5-Fluorouracil,%20innovative%20drug%20delivery%20systems%20to%20enhance%20bioavailability%20for%20topical%20use&rft.jtitle=Journal%20of%20drug%20delivery%20science%20and%20technology&rft.au=Ewert%20de%20Oliveira,%20Beatriz&rft.date=2021-02&rft.volume=61&rft.spage=102155&rft.pages=102155-&rft.artnum=102155&rft.issn=1773-2247&rft_id=info:doi/10.1016/j.jddst.2020.102155&rft_dat=%3Celsevier_cross%3ES1773224720314441%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c303t-9c918eabca6c20bc37ed45b38f0e6ff470292409509e990e81d9dfd669e5f5f53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true